Why Is Core Laboratories (CLB) Down 5.9% Since Last Earnings Report?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
Core Laboratories Down 30% YTD: Should You Hold or Sell the Stock?
CLB struggles with a 4.4% revenue decline, low ROIC in the first quarter of 2025, minimal dividends and vulnerability to oil price volatility and geopolitical instability.
Core Laboratories Q1 Earnings Miss Estimates, Expenses Increase YoY
CLB's first-quarter earnings miss estimates due to the underperformance of the Reservoir Description segment.
Core Laboratories Inc. (CLB) Q1 2025 Earnings Call Transcript
Core Laboratories Inc. (NYSE:CLB ) Q1 2025 Earnings Conference Call April 24, 2025 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Gwen Gresham - Senior Vice President and Head, Investor Relations Chris Hill - Chief Financial Officer Conference Call Participants Stephen Gengaro - Stifel Sean Mitchell - Daniel Energy Partners Operator Good day, and welcome to the Core Laboratories First Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
Core Laboratories (CLB) Q1 Earnings and Revenues Lag Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.19 per share a year ago.
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch
CLB's first-quarter revenues are likely to have declined from the year-ago period's level. However, cost reductions are expected to have provided modest relief.
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How to Play Core Labs Stock Ahead of Its Q1 Earnings Release
CLB faces declining revenues, weak margins, geopolitical disruptions and inventory issues, with low dividend yield and overvaluation increasing investor caution.
CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025.
Is Core Stock Worth Buying After a 27% Surge in 6 Months?
CLB stock is supported by international expansion, proprietary tech and solid cash flow amid competitive pricing, volatile oil prices and geopolitical tensions.
Why Is Core Laboratories (CLB) Down 16% Since Last Earnings Report?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
CLB's Q4 Earnings Beat Estimates, Sales Lag, Expenses Increase
Core Laboratories expects Reservoir Description revenues of $82-$85 million and Production Enhancement revenues of $39-$42 million for the first quarter of 2025.
